256 related articles for article (PubMed ID: 21936632)
1. A case hypersensitive to bimatoprost and dexamethasone.
Li X; Liu G; Wang Y; Yu W; Xiang H; Liu X
J Ocul Pharmacol Ther; 2011 Oct; 27(5):519-23. PubMed ID: 21936632
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
Noecker RJ; Walt JG
Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S15-21. PubMed ID: 16389056
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.
Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301
[TBL] [Abstract][Full Text] [Related]
4. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
Ota T; Aihara M; Narumiya S; Araie M
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
[TBL] [Abstract][Full Text] [Related]
6. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys.
Gabelt BT; Hennes EA; Bendel MA; Constant CE; Okka M; Kaufman PL
J Ocul Pharmacol Ther; 2009 Feb; 25(1):1-8. PubMed ID: 19232013
[TBL] [Abstract][Full Text] [Related]
8. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
Gagliuso DJ; Wang RF; Mittag TW; Podos SM
Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
Centofanti M; Oddone F; Gandolfi S; Hommer A; Boehm A; Tanga L; Sangermani C; Sportelli V; Haustein M; Manni G; Rossetti L
Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
[TBL] [Abstract][Full Text] [Related]
11. Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost.
Sakurai M; Higashide T; Takahashi M; Sugiyama K
Ophthalmology; 2007 Jun; 114(6):1039-45. PubMed ID: 17467803
[TBL] [Abstract][Full Text] [Related]
12. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
Cantor LB; WuDunn D; Cortes A; Hoop J; Knotts S
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
[TBL] [Abstract][Full Text] [Related]
13. Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.
Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
J Ocul Pharmacol Ther; 2008 Oct; 24(5):517-20. PubMed ID: 18800869
[TBL] [Abstract][Full Text] [Related]
14. Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.
Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
Am J Manag Care; 2011 Sep; 17(9):e365-74. PubMed ID: 21902444
[TBL] [Abstract][Full Text] [Related]
15. 24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension.
Hepsen IF; Ozkaya E
Eye (Lond); 2007 Apr; 21(4):453-8. PubMed ID: 16543930
[TBL] [Abstract][Full Text] [Related]
16. The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery.
Arici MK; Erdogan H; Toker I; Vural A; Topalkara A
J Ocul Pharmacol Ther; 2006 Feb; 22(1):34-40. PubMed ID: 16503773
[TBL] [Abstract][Full Text] [Related]
17. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
Simmons ST; Bernstein P; Hollander DA
Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.
Quaranta L; Pizzolante T; Riva I; Haidich AB; Konstas AG; Stewart WC
Br J Ophthalmol; 2008 Sep; 92(9):1227-31. PubMed ID: 18586898
[TBL] [Abstract][Full Text] [Related]
19. Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice.
Crowston JG; Lindsey JD; Morris CA; Wheeler L; Medeiros FA; Weinreb RN
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4571-7. PubMed ID: 16303950
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
Aptel F; Cucherat M; Denis P
J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
